Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Relief for baby and child care at the UFS with donation from Fuchs Foundation
2007-11-17

 

At the launch of the Beds of Hope campaign were, from the left: Dr Riaan Els, Chief Executive Officer of the Carl en Emily Fuchs Foundation, Prof. André Venter (Head of the Department of Paediatrics and Child Care), Ms Corné Booyens (National Grants Manager at the Carl en Emily Fuchs Foundation), Dr Nick van Zyl (Clinical Head at Universitas Hospital), and Prof. Niel Viljoen (Chief Director: Operations).
Photo: Leonie Bolleurs

Relief for baby and child care at the UFS with donation from Fuchs Foundation

The Department of Paediatrics and Child Health at the University of the Free State (UFS) has received relief for their need of specialised healthcare for babies and children with a donation of R1,5 million from the Carl and Emily Fuchs Foundation.

As a result of this, the Beds of Hope campaign was launched today on the Main Campus in Bloemfontein. With the campaign, the department wants to address the serious need for specialised healthcare for babies and children in the central regions of South Africa.

The department is one of four out of 19 children hospitals in South Africa to receive such a donation. .

“We take care of babies and children in the Universitas and Pelonomi Hospitals in Bloemfontein who have a serious need for specialised healthcare. We are, however, the only supplier of this kind of care in the Free State, North West, Eastern Cape and Lesotho and are responsible for the specialised healthcare of more than 100 000 children. Many of our equipment are outdated and must be urgently repaired or replaced,” said Prof. André Venter, Head of the Department of Paediatrics and Child Care at the UFS.

“Because we are concerned about our patients, the department launched the Beds of Hope campaign with the help of the donation we received from the Fuchs Foundation. With the campaign, we aim to raise some R15 million in the space of two years to purchase beds and specialised equipment for the intensive care and high care units for both hospitals,” said Prof. Venter.
According to Prof. Venter, this includes babies and children with needs for specialised healthcare in the fields of intensive care, oncology, cardiology, neurology, endocrinology, gastro-enterology, neonatology and infectious diseases.

“About ten children are currently not receiving the care they need due to the lack of beds in the intensive care unit. Much more neonates can annually receive critical care if we can supply adequate facilities,” said Prof. Venter.

The other hospitals that are also supported by the Fuchs Foundation’s donation are: Healing Jozi Kids, Boikanyo Foundation and the Groote Schuur Hospital’s neonatal department.

The donation is the beginning of the first phase of the national Fuchs Healing Kids Project, which aims to improve the quality of paediatric care in South Africa.

The aim of this phase is to assist the hospitals to develop the systems and skills needed to collect more money. The research part of phase two and the building up of the hospitals’ children trust funds to be self self-supporting, will happen simultaneously. This phase will be launched early in 2008.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
16 November 2007
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept